Impact of Lifting Nuclear Sanctions on Iran’s Healthcare Market—Now and Later
Several international sanctions were imposed over Iran over the last decade, restraining its international trade capacities. Yet, Iran is the 17th largest economy in the world; its Gross Domestic Product (GDP) was $ billion in 2014.
The nuclear sanctions imposed by the United Nations on Iran resulted in trade bans and restrictions on financial transactions, severely affecting the pharmaceutical and medical tourism sectors.
Despite the import of food and drugs being exempted from sanctions, there has been a shortage of imported drugs due to financial road blocks such as restrictions on SWIFT payment methods.
From 2015 onwards, there is an increasing international consensus to ease nuclear sanctions. This will likely allow the Iranian pharmaceutical sector to produce adequate drugs needed for domestic use. This will also improve the prospect of Iran opening up to trade and providing opportunities for pharmaceutical companies to be a part of its growth. Frost & Sullivan expects that by mid-2016, there will be a positive momentum to support lifting of sanctions over Iran, especially by the US Congress while the International Atomic Energy Agency (IAEA) verifies Iran’s compliance with nuclear deal requirements.
Frost & Sullivan expects that this ease will increase the import of drugs as well as boost manufacturing from the pharmaceutical companies for generic drugs licensed by European and US companies.
The government of Iran is more reform-oriented to position Iran as a business friendly nation, and it took effective measures to bring inflation under control at% in the first half of 2015 .
International companies have gradually started to leverage this positive environment. Novo Nordisk plans to build a manufacturing plant for approximately $ million (€ million) in Iran. Iranian companies benefit with increased access to finance and technology, while the Iranian people will benefit from a competitive healthcare landscape and improved value for money.
Electronic Access - Site License Fulfilled By Publisher
Electronic Access - Global site License Fulfilled By Publisher